Liver X Receptor as a Possible Drug Target for Blood-Brain Barrier Integrity

Mahsa Eskandari ¹ , Ali Awsat Mellati ² *

Cited by CrossRef: 4

1- Huang R, Pang Q, Zheng L, Lin J, Li H, Wan L, Wang T. Cholesterol metabolism: physiological versus pathological aspects in intracerebral hemorrhage. 2025;20(4):1015 [Crossref]

2- Nazeri Z, Mohammadzadeh G, Rashidi M, Azizdoost S, Cheraghzadeh M, Kheirollah A. 24-Hydroxycholesterol Moderates the Effects of Amyloid-β on Expression of HMG-CoA Reductase and ABCA1 Proteins in Mouse Astrocytes. 2023;12(1) [Crossref]

3- Zhang R, Wuerch E, Yong V, Xue M. LXR agonism for CNS diseases: promises and challenges. J Neuroinflammation. 2024;21(1) [Crossref]

4- Xu Y, Xu L, Xu C, Zhao M, Xu T, Xia L, Wu Y, Cao Y, Han Z. PSD-95 inhibitor Tat-NR2B9c (NA-1) protects the integrity of the blood-brain barrier after transient middle artery occlusion in rats by downregulating matrix metalloprotease-9 and upregulating endothelial nitric oxide synthase. Brain Research Bulletin. 2024;206:110836 [Crossref]